Registration Dossier

Administrative data

Description of key information

Key value for chemical safety assessment

Skin sensitisation

Endpoint conclusion
Endpoint conclusion:
no adverse effect observed (not sensitising)
Additional information:
Migrated from Short description of key information:
A recent guideline study (LLNA) is available. Gallium arsenide did not reveal any sensitising properties in the local lymph node assay.

Justification for classification or non-classification

A recent guideline study (LLNA) is available. Gallium arsenide did not reveal any sensitising properties in the local lymph node assay.

According to Regulation (EC) No. 1272/2008 and subsequent regulations, the test item is not classified as skin sensitiser.

Also, according to the criteria specified by Directive 67/548/EEC and subsequent regulations, the test item is not classified as skin sensitiser.